These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 29448290)

  • 21. Fully automatic quantification of transient severe respiratory motion artifact of gadoxetate disodium-enhanced MRI during arterial phase.
    Jang J; Chung YE; Kim S; Hwang D
    Med Phys; 2022 Nov; 49(11):7247-7261. PubMed ID: 35754384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Respiratory motion artefacts in dynamic liver MRI: a comparison using gadoxetate disodium and gadobutrol.
    Luetkens JA; Kupczyk PA; Doerner J; Fimmers R; Willinek WA; Schild HH; Kukuk GM
    Eur Radiol; 2015 Nov; 25(11):3207-13. PubMed ID: 25903709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transient Respiratory-motion Artifact and Scan Timing during the Arterial Phase of Gadoxetate Disodium-enhanced MR Imaging: The Benefit of Shortened Acquisition and Multiple Arterial Phase Acquisition.
    Ichikawa S; Motosugi U; Sato K; Shimizu T; Wakayama T; Onishi H
    Magn Reson Med Sci; 2021 Sep; 20(3):280-289. PubMed ID: 32863326
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of acute transient dyspnea after intravenous administration of gadoxetate disodium and gadobenate dimeglumine: effect on arterial phase image quality.
    Davenport MS; Viglianti BL; Al-Hawary MM; Caoili EM; Kaza RK; Liu PS; Maturen KE; Chenevert TL; Hussain HK
    Radiology; 2013 Feb; 266(2):452-61. PubMed ID: 23192781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transient severe motion in the arterial phase during gadoxetate disodium-enhanced MR imaging: evaluation of patients with multiple MR examinations.
    Im WH; Song JS; Park EH; Kwak HS
    Abdom Radiol (NY); 2017 Oct; 42(10):2393-2401. PubMed ID: 28396919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of transient severe motion in gadoxetate disodium and gadopentetate dimeglumine-enhanced MRI: effect of modified breath-holding method.
    Song JS; Choi EJ; Park EH; Lee JH
    Eur Radiol; 2018 Mar; 28(3):1132-1139. PubMed ID: 28986630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gadoxetate disodium-enhanced MRI: Assessment of arterial phase artifacts and hepatobiliary uptake in a large series.
    Vietti Violi N; Argiriadi P; Rosen A; Cherny M; Weiss A; Hernandez-Meza G; Babb JS; Kihira S; Lewis S; Taouli B
    Eur J Radiol; 2020 Nov; 132():109313. PubMed ID: 33053495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compressed Sensing and Parallel Imaging for Double Hepatic Arterial Phase Acquisition in Gadoxetate-Enhanced Dynamic Liver Magnetic Resonance Imaging.
    Yoon JK; Kim MJ; Lee S
    Invest Radiol; 2019 Jun; 54(6):374-382. PubMed ID: 30724814
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gadoxetate Disodium versus Gadoterate Meglumine: Quantitative Respiratory and Hemodynamic Metrics by Using Compressed-Sensing MRI.
    Glessgen CG; Moor M; Stieltjes B; Winkel DJ; Block TK; Merkle EM; Heye TJ; Boll DT
    Radiology; 2019 Nov; 293(2):317-326. PubMed ID: 31549944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are dilution, slow injection and care bolus technique the causal solution to mitigating arterial-phase artifacts on gadoxetic acid-enhanced MRI? A large-cohort study.
    Poetter-Lang S; Ambros R; Messner A; Kristic A; Hodge JC; Bastati N; Schima W; Chernyak V; Bashir MR; Ba-Ssalamah A
    Eur Radiol; 2024 Aug; 34(8):5215-5227. PubMed ID: 38243134
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reducing artifacts of gadoxetate disodium-enhanced MRI with oxygen inhalation in patients with prior episode of arterial phase motion: intra-individual comparison.
    Namimoto T; Shimizu K; Nakagawa M; Kikuchi Y; Kidoh M; Oda S; Nakaura T; Utsunomiya D; Yamashita Y
    Clin Imaging; 2018; 52():11-15. PubMed ID: 29494992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Observer reliability of arteriovenous malformations grading scales using current imaging modalities.
    Griessenauer CJ; Miller JH; Agee BS; Fisher WS; Curé JK; Chapman PR; Foreman PM; Fisher WA; Witcher AC; Walters BC
    J Neurosurg; 2014 May; 120(5):1179-87. PubMed ID: 24628617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transient arterial phase respiratory motion-related artifact in MR imaging of the liver: an analysis of four different gadolinium-based contrast agents.
    Shah MR; Flusberg M; Paroder V; Rozenblit AM; Chernyak V
    Clin Imaging; 2017; 41():23-27. PubMed ID: 27736700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artifacts during the arterial phase of gadoxetate disodium-enhanced MRI: Multiple arterial phases using view-sharing from two different vendors versus single arterial phase imaging.
    Min JH; Kim YK; Kang TW; Jeong WK; Lee WJ; Ahn S; Hwang NY
    Eur Radiol; 2018 Aug; 28(8):3335-3346. PubMed ID: 29450712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A low albumin level as a risk factor for transient severe motion artifact induced by gadoxetate disodium administration: A retrospective observational study with free-breathing dynamic MRI and an experimental study in rats.
    Sugiura T; Okumura K; Sasaki M; Matsumoto J; Ogi T; Yoneda N; Kitao A; Kozaka K; Koda W; Kobayashi S; Gabata T
    PLoS One; 2022; 17(3):e0265588. PubMed ID: 35303023
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reducing Artifacts during Arterial Phase of Gadoxetate Disodium-enhanced MR Imaging: Dilution Method versus Reduced Injection Rate.
    Kim YK; Lin WC; Sung K; Raman SS; Margolis D; Lim Y; Gu S; Lu D
    Radiology; 2017 May; 283(2):429-437. PubMed ID: 27977329
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abdominal vasculature in dynamic contrast-enhanced liver MRI at 3.0T: an intraindividual comparative study using gadoxetate disodium and gadofosveset trisodium.
    Kupczyk PA; Willinek WA; Hadizadeh DR; Traeber F; Gieseke J; Meyer C; Schild HH; Kukuk GM
    Magn Reson Imaging; 2015 Dec; 33(10):1258-1266. PubMed ID: 26271178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does transient arterial-phase respiratory-motion-related artifact impact on diagnostic performance? An intra-patient comparison of extracellular gadolinium versus gadoxetic acid.
    Rimola J; Darnell A; Belmonte E; Sapena V; Caparroz C; Llarch N; Reig M; Forner A; Bruix J; Ayuso C
    Eur Radiol; 2020 Dec; 30(12):6694-6701. PubMed ID: 32607632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of hepatocellular phase imaging after intravenous gadoxetate disodium for assessing hepatic metastases from gastroenteropancreatic neuroendocrine tumors: comparison with other MRI pulse sequences and with extracellular agent.
    Tirumani SH; Jagannathan JP; Braschi-Amirfarzan M; Qin L; Balthazar P; Ramaiya NH; Shinagare AB
    Abdom Radiol (NY); 2018 Sep; 43(9):2329-2339. PubMed ID: 29470627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of Liver Imaging Reporting and Data System 2017 (LI-RADS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma.
    Kierans AS; Makkar J; Guniganti P; Cornman-Homonoff J; Lee MJ; Pittman M; Askin G; Hecht EM
    J Magn Reson Imaging; 2019 Jun; 49(7):e205-e215. PubMed ID: 30257054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.